Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
about
Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast CancerHER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature reviewAn integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological preventionA shared transcriptional program in early breast neoplasias despite genetic and clinical distinctions.HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions.Targeted therapy in breast cancer: the HER-2/neu gene and protein.Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors.Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma.HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.Variation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literature.HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis.Variability in hormone and growth factor receptor expression in primary versus recurrent, metastatic, and post-neoadjuvant breast carcinoma.Latest biopsy approach for suspected metastases in patients with breast cancer.Concordance of the hormone receptors and correlation of HER-2/neu overexpression of the metachronous cancers of contralateral breasts.Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours-a review.Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions.A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice.Liquid Biopsy Prevents Inaccurate Her2 Status Determination by in situ Hybridization in a Patient with Invasive Ductal Adenocarcinoma of the Breast: Case Report.Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases.Clinicopathological significance of HER2/neu genetic heterogeneity in HER2/neu non-amplified invasive breast carcinomas and its concurrent axillary metastasis.Comparison of fluorescent in situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer.Molecular profile of atypical hyperplasia of the breast.Canine mammary mixed tumours: immunohistochemical expressions of EGFR and HER-2.Concordance of the HER2 protein and gene status between primary and corresponding lymph node metastatic sites of extramammary Paget disease.Characterization of the timing and prevalence of receptor tyrosine kinase expression changes in oesophageal carcinogenesis.Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape.
P2860
Q26738987-3F5354CF-B06C-44C3-A06D-DD9A48960752Q30932448-5D403C82-320C-4FBD-A1C0-0F6C55E3F9EEQ33229377-EB2A8382-0BBD-4E87-A33F-13608BFB47D8Q33813317-B03C9B71-41B6-4AC8-8083-A76E3EF41021Q34324291-A45BCC1C-BEB8-4C94-958B-83B346349B2CQ35648508-FF56D360-8707-44D9-B5E5-FB7299ACBA69Q35808400-37E094C9-8BDE-478E-B97D-12F359B665C2Q35846896-E30D900B-3FC1-4433-8BC7-44490933FCD2Q37015151-DAB1C3BB-B04F-4B20-9722-616E72E54EF6Q37812122-43A158E7-CC8D-47B7-BCDC-490002A59F79Q37893534-0C0C813D-42F1-4B4C-9657-FC935E06BCE0Q38000948-9EF8BF91-C9C7-41B3-B8BC-AD113C93B9CCQ38154494-E0B7B1DB-C00C-4530-B4D1-6F4A7FC0039BQ38442917-A052C89D-5198-4B4C-A88B-63589F7F0E00Q38842674-5BEB2ED3-C360-4FA6-B068-1479B2CBC77FQ40328917-1D59D26C-9A5C-4D9F-BE21-FD6881C12B06Q40423857-1ABD4F36-F1E3-468D-BC29-52C9E8539AA8Q42667963-7A644F08-7759-4C7D-8A45-401DB7D8D2C0Q43254569-98FED783-481C-434F-88B3-DCCBB073717FQ44505402-00E633BA-BBDF-4C6C-B6AC-5F8DEAD8094DQ47685193-E061BC5A-9BBC-4EFF-B1B3-3567FADC172CQ47947859-7C861F93-D247-4F88-B708-6F0D914035C0Q51433095-5243F3A1-8B50-4A38-B1A2-AA12F74303F6Q51707520-E97056C8-0DC9-4828-8619-8D4B1E8234C4Q54501808-09EDE538-B9C8-4192-BB49-6C59A61C90E0Q55309670-DD91A729-9580-437D-B80A-1F5F916FB552
P2860
Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Amplification of Her-2/neu gen ...... by FISH in archival material.
@ast
Amplification of Her-2/neu gen ...... by FISH in archival material.
@en
Amplification of Her-2/neu gen ...... by FISH in archival material.
@nl
type
label
Amplification of Her-2/neu gen ...... by FISH in archival material.
@ast
Amplification of Her-2/neu gen ...... by FISH in archival material.
@en
Amplification of Her-2/neu gen ...... by FISH in archival material.
@nl
prefLabel
Amplification of Her-2/neu gen ...... by FISH in archival material.
@ast
Amplification of Her-2/neu gen ...... by FISH in archival material.
@en
Amplification of Her-2/neu gen ...... by FISH in archival material.
@nl
P2093
P2860
P1433
P1476
Amplification of Her-2/neu gen ...... by FISH in archival material.
@en
P2093
Giorgio Inghirami
Helen Feiner
Mary Ann Perle
Ruliang Xu
Yara Delgado
P2860
P2888
P304
P356
10.1038/MODPATHOL.3880503
P577
2002-02-01T00:00:00Z
P5875
P6179
1034705567